These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23811589)

  • 1. [Bone structural properties and bone strength in CKD].
    Yano S; Sugimoto T
    Clin Calcium; 2013 Jul; 23(7):1007-12. PubMed ID: 23811589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Updates on Lifestyle-Related Diseases and Bone Metabolism. Increase in bone fragility from the viewpoint of bone structural properties].
    Ito M; Chiba K
    Clin Calcium; 2014 Nov; 24(11):1615-20. PubMed ID: 25355145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate chronic kidney disease impairs bone quality in C57Bl/6J mice.
    Heveran CM; Ortega AM; Cureton A; Clark R; Livingston EW; Bateman TA; Levi M; King KB; Ferguson VL
    Bone; 2016 May; 86():1-9. PubMed ID: 26860048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cortical bone in bone fragility.
    Bala Y; Zebaze R; Seeman E
    Curr Opin Rheumatol; 2015 Jul; 27(4):406-13. PubMed ID: 26002033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Biomechanical Testing for the Assessment of Bone Quality in an Experimental Model of Chronic Kidney Disease.
    Oksztulska-Kolanek E; Znorko B; Michałowska M; Pawlak K
    Nephron; 2016; 132(1):51-8. PubMed ID: 26680019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.
    Iwasaki Y; Kazama JJ; Yamato H; Fukagawa M
    Bone; 2011 Jun; 48(6):1260-7. PubMed ID: 21397740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging.
    Duan Y; Beck TJ; Wang XF; Seeman E
    J Bone Miner Res; 2003 Oct; 18(10):1766-74. PubMed ID: 14584886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone biopsy: an ally in the management of fragility fractures in chronic kidney disease.
    Aguiar F; Meng C; Pereira L; Brito I; Frazão JM
    Acta Reumatol Port; 2018; 43(3):201-209. PubMed ID: 30414368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of naturally occurring chronic kidney disease on the micro-structural and mechanical properties of bone.
    Shipov A; Segev G; Meltzer H; Milrad M; Brenner O; Atkins A; Shahar R
    PLoS One; 2014; 9(10):e110057. PubMed ID: 25333360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions.
    Newman CL; Chen NX; Smith E; Smith M; Brown D; Moe SM; Allen MR
    Bone; 2015 Aug; 77():50-6. PubMed ID: 25892482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic material property differences in bone tissue from patients suffering low-trauma osteoporotic fractures, compared to matched non-fracturing women.
    Vennin S; Desyatova A; Turner JA; Watson PA; Lappe JM; Recker RR; Akhter MP
    Bone; 2017 Apr; 97():233-242. PubMed ID: 28132909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKD Stages, Bone Metabolism Markers, and Cortical Porosity Index: Associations and Mediation Effects Analysis.
    Xiong Y; He T; Wang Y; Liu WV; Hu S; Zhang Y; Wen D; Hou B; Li Y; Zhang P; Liu J; He F; Li X
    Front Endocrinol (Lausanne); 2021; 12():775066. PubMed ID: 34803931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone microdamage and skeletal fragility in osteoporotic and stress fractures.
    Burr DB; Forwood MR; Fyhrie DP; Martin RB; Schaffler MB; Turner CH
    J Bone Miner Res; 1997 Jan; 12(1):6-15. PubMed ID: 9240720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mass measurements in men and women with chronic kidney disease.
    Jamal SA
    Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):343-8. PubMed ID: 20414109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice.
    Heveran CM; Schurman CA; Acevedo C; Livingston EW; Howe D; Schaible EG; Hunt HB; Rauff A; Donnelly E; Carpenter RD; Levi M; Lau AG; Bateman TA; Alliston T; King KB; Ferguson VL
    Bone; 2019 Oct; 127():91-103. PubMed ID: 31055118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.
    McNerny EMB; Nickolas TL
    Curr Osteoporos Rep; 2017 Jun; 15(3):207-213. PubMed ID: 28447312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical and trabecular bone distribution in the femoral neck in osteoporosis and osteoarthritis.
    Blain H; Chavassieux P; Portero-Muzy N; Bonnel F; Canovas F; Chammas M; Maury P; Delmas PD
    Bone; 2008 Nov; 43(5):862-8. PubMed ID: 18708176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New Developments in CKD-MBD. Efficacy and safety of antiosteoporotic agents in CKD].
    Kazama JJ
    Clin Calcium; 2014 Dec; 24(12):1831-7. PubMed ID: 25423929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorder.
    Costa AG; Bilezikian JP; Lewiecki EM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):324-9. PubMed ID: 26050118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for vibrational assessment of cortical bone.
    Song Y; Gunaratne GH
    Chaos; 2006 Sep; 16(3):033102. PubMed ID: 17014207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.